ATNT, short for Advanced Technologies for Novel Therapeutics, is a biotech company dedicated to pioneering protein discovery using patented technologies. The company offers unique services to pharmaceutical and biotech firms, focusing on identifying the most important therapeutic targets in complex cellular networks. Founded by well-recognized university professors with expertise in molecular biology, cell biology, biochemistry, and related fields, ATNT leverages cross-disciplinary engineering methods to develop novel tools and techniques for treating complex human disorders.
ATNT has achieved significant recognition, including the President & CEO being selected to receive the New Jersey Inventors Hall of Fame Award. This accolade highlights the company's innovative contributions to biotechnology. With a team of high-profile experts in engineering and biology, ATNT continues to impact the pharmaceutical and biotech industries by providing advanced solutions for therapeutic target identification.
